Early Detection of Lung Cancer Using Serum RNA or DNA Markers: Ready for “Prime Time” or for Validation?
- 1 November 2003
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 21 (21) , 3891-3893
- https://doi.org/10.1200/jco.2003.07.976
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Quantification of Free Circulating DNA As a Diagnostic Marker in Lung CancerJournal of Clinical Oncology, 2003
- Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patientsCancer Letters, 2003
- Circulating RNA as a Tumor MarkerAnnals of the New York Academy of Sciences, 2001
- Detection of microsatellite instability and loss of heterozygosity in serum DNA of small and non-small cell lung cancer patients: a tool for early diagnosis?Lung Cancer, 2000
- Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significanceAnnals of Oncology, 2000
- Lung Cancer Mortality in the Mayo Lung Project: Impact of Extended Follow-upJNCI Journal of the National Cancer Institute, 2000
- Detection of Microsatellite Alterations in the DNA Isolated from Tumor Cells and from Plasma DNA of Patients with Lung CancerAnnals of the New York Academy of Sciences, 2000
- Microsatellite alterations in plasma DNA of small cell lung cancer patientsNature Medicine, 1996
- Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumoursCancer Letters, 1995